Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01349218 · ClinicalTrials.gov registry record · NA
Relationship Between Potassium Level in Venous Blood Samples Drawn and Heel Sticks In Infants and Newborns
A NA study of Hyperkalemia, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
- 1
- Study location
NCT01349218 is a NA study of Hyperkalemia that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 31 participants, below the 58-participant average among 8 other Hyperkalemia trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01349218, a NA study of Hyperkalemia, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to find out whether there is a correlation (link) between the level of potassium in blood samples drawn from a vein and those drawn from a heel stick in infants scheduled for elective surgery.
Conditions Studied
Interventions
- OTHER Blood sample drawn from a vein
- OTHER Blood sample drawn from a heel stick
Study Locations (1)
Texas
- Memorial Hermann Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2014-03 |
| Est. Completion | 2014-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01349218
The ClinicalTrials.gov registry entry for NCT01349218 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 58-participant average among 8 other Hyperkalemia trials with a reported enrollment target (47% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hyperkalemia appearing as the primary indexed condition, and to 2 interventions - of which Blood sample drawn from a vein is the first listed.
NCT01349218 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01349218 about?
NCT01349218 is a clinical study titled "Relationship Between Potassium Level in Venous Blood Samples Drawn and Heel Sticks In Infants and Newborns". The purpose of this study is to find out whether there is a correlation (link) between the level of potassium in blood samples drawn from a vein and those drawn from a heel stick in infants scheduled for elective surgery.
What is the current status of trial NCT01349218?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2014-03. Estimated completion is 2014-03.
What conditions does trial NCT01349218 study?
This clinical trial studies the following conditions: Hyperkalemia.
What interventions are being tested in trial NCT01349218?
The interventions under investigation include: Blood sample drawn from a vein (OTHER), Blood sample drawn from a heel stick (OTHER).
Who is sponsoring clinical trial NCT01349218?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01349218 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hyperkalemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age
RECRUITING · Phase 2
-
AK+ Guard™ Pilot Study in Chronic Kidney Disease: Outpatient Diagnostic Accuracy and Remote Monitoring
RECRUITING
-
Adding Urea to the Final Dialysis Fluid
RECRUITING · Phase 1
-
Safety & Efficacy of Zirconium Silicate in Chronic Kidney Disease or Moderate Kidney Dysfunction With Mild Hyperkalemia
COMPLETED · Phase 2
-
Patiromer Efficacy to Reduce Episodic Hyperkalemia in End Stage Renal Disease Patients
COMPLETED · Phase 4
-
Pharmacokinetic Study of Tacrolimus and Mycophenolate Mofetil in Kidney Transplant Recipients With Hyperkalemia Receiving Patiromer
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.